ScienceDex / Researcher record
Cope, Frederick Oliver
- Navidea Biopharmaceuticals, Inc. (no department on record)
From the FY2016 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2016
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2012 | $315,217 | 1 | #25,217 |
| 2013 | $410,638 | 2 | #17,518 |
| 2014 | $2,052,514 | 3 | #2,797 |
| 2015 | $1,384,966 | 4 | #4,580 |
| 2016 | $2,679,756 | 4 | #1,692 |
| 2017 | $1,313,887 | 2 | #4,864 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20121 record
- FY20132 records
- FY20143 records
- FY20154 records
- FY2016 · selected4 records
- FY20172 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2017Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2016 award records by amount
NIH award records listing Cope, Frederick Oliver as a PI. Multi-PI records show the full award amount for context.
- 4R44AR067583-02R44Contact PI99mTc-Tilmanocept for Targeting Rheumatoid Arthritis (RA)-Driving Macrophages$1.1Maward amount
- 5R44CA162783-03R44Contact PICC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv$688.1Kaward amount
- 4R44CA192859-02R44Contact PIReceptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept$633.5Kaward amount
- 1R44CA206788-01R44Contact PICD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages$232.5Kaward amount
Award organization
Organizations that administered FY2016 awards listing Cope, Frederick Oliver as a PI.
FY2016 award administered by Navidea Biopharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardNavidea Biopharmaceuticals, Inc.
- 2013$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #2797
- 2014Entered Top 25% NationallyRanked #2797
- 2016$5M Cumulative Funding
- 2016Entered Top 10% NationallyRanked #1692